Advertisement

Dietary Antioxidants and Infectious Diseases

  • Jasleen Kaur
  • Rajvir Kaur
  • Amarjeet Kaur
Chapter

Abstract

The role of antioxidants in helping to prevent diseases such as cancer, cardiovascular diseases and various neurodegenerative disorders arising due to oxidative stress has long been recognised. But recent researches have also highlighted their importance in progression and control of infectious diseases. Antioxidants can be endogenously produced by human body or externally supplied through foods and/or supplements. Dietary antioxidants have been related to modulate the host susceptibility or resistance to infectious diseases. This chapter focuses on the beneficiary effects of dietary antioxidants in limiting and preventing the progression of infectious diseases. Antioxidants can help in fighting infectious diseases in several ways. In addition to ameliorating the deteriorating and degenerative effects of reactive species, they also help in building or maintaining healthy immune cells to fight the pathogens. Many pathogens and their metabolites produce free radicals which help in establishing their virulence and pathogenicity. Antioxidants aid in limiting the progression by neutralising the free radicals. Some dietary antioxidants like phenolics and flavonoids also possess antimicrobial activities. Antimicrobial activities can be attributed to their ability to inhibit various enzymes and physiological processes in bacteria and viruses. Phenolics can also form complexes with proteins such as microbial adhesins, enzymes and cell envelope transport proteins and inactivate them. Alterations in membrane fluidity and quorum sensing inhibition by these molecules can also contribute to their antimicrobial activities.

Keywords

Antimicrobial agents Antioxidants Free radicals Infectious diseases 

References

  1. Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Ronnenberg AG, Contreras C, Yataco R (2017) Impact of vitamin A and carotenoids on the risk of tuberculosis progression. Clin Infect Dis 15(65):900–909CrossRefGoogle Scholar
  2. Alves MJ, Ferreira IC, Froufe HJ, Abreu RM, Martins A, Pintado M (2013) Antimicrobial activity of phenolic compounds identified in wild mushrooms, SAR analysis and docking studies. J Appl Microbiol 115:346–357CrossRefGoogle Scholar
  3. Anderson R (1984) The immunostimulatory, anti-inflammatory and anti-allergic properties of ascorbate. Adv Nutr Res 6:619–645Google Scholar
  4. Aruoma OI (1999) Free radicals, antioxidants and international nutrition. Asia Pac J Clin Nutr 8:53–63CrossRefGoogle Scholar
  5. Balde AM, Van Hoof L, Pieters LA, Vanden Berghe DA, Vlietinck AJ (1990) Plant antiviral agents. VII. Antiviral and antibacterial proanthocyanidins from the bark of Pavetta owariensis. Phytother Res 4:182–188CrossRefGoogle Scholar
  6. Bernard FX, Sable S, Cameron B, Provost J, Desnottes JF, Crouzet J, Blanche F (1997) Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob Agents Chemother 41:99–98CrossRefGoogle Scholar
  7. Beveridge S, Wintergerst ES, Maggini S, Hornig D (2008) Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Proc Nutr Soc 1:67 (OCE)Google Scholar
  8. Bissell MJ, Hatie C, Farson DA, Schwarz RI, Soo WJ (1980) Ascorbic acid inhibits replication and infectivity of avian RNA tumor virus. Proc Natl Acad Sci 77:2711–2715CrossRefGoogle Scholar
  9. Borris RP (1996) Natural products research: perspectives from a major pharmaceutical company. J Ethnopharmacol 41:587–590Google Scholar
  10. Chen Y, Liu T, Wang K, Hou C, Cai S, Huang Y et al (2016) Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro. PLoS One 11:e0153468CrossRefGoogle Scholar
  11. Cowan MM (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12:564–582CrossRefGoogle Scholar
  12. Critchfield JW, Butera ST, Folks TM (1996) Inhibition of HIV activation in latently infected cells by flavonoid compounds. AIDS Res Hum Retrovir 12:39–46CrossRefGoogle Scholar
  13. Cushnie TP, Lamb AJ (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26:343–356CrossRefGoogle Scholar
  14. Ding SZ, Minohara Y, Fan XJ, Wang J, Reyes VE, Patel J et al (2007) Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun 75:4030–4039CrossRefGoogle Scholar
  15. Elswaifi SF, Palmieri JR, Hockey KS, Rziqalinski BA (2009) Antioxidant nanoparticles for control of infectious disease. Infect Disord Drug Targets 9:445–452CrossRefGoogle Scholar
  16. Estevinho L, Pereira AP, Moreira L, Dias LG, Pereira E (2008) Antioxidant and antimicrobial effects of phenolic compounds extracts of Northeast Portugal honey. Food Chem Toxicol 31:3774–3379CrossRefGoogle Scholar
  17. Fawzi WW, Msamanga GI, Wei R, Spiegelman D, Antelman G, Villamor E, Manji K, Hunter D (2003) Effect of providing vitamin supplements to human immunodeficiency virus-infected, lactating mothers on the child’s morbidity and CD4+ cell counts. Clin Infect Dis 36:1053–1062CrossRefGoogle Scholar
  18. Fiorino S, Bacchi-Reggiani ML, Leandri P, Loggi E, Andreone P (2017) Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: a systematic review and meta-analysis. World J Hepatol 9:333CrossRefGoogle Scholar
  19. Gonçalves D, Lima C, Ferreira P, Costa P, Costa A, Figueiredo W, Cesar T (2017) Orange juice as dietary source of antioxidants for patients with hepatitis C under antiviral therapy. Food Nutr Res 61(1):1296675CrossRefGoogle Scholar
  20. Griep MA, Blood S, Larson MA, Koepsell SA, Hinrichs SH (2007) Myricetin inhibits Escherichia coli DnaB helicase but not primase. Bioorg Med Chem 15:7203–7208CrossRefGoogle Scholar
  21. Hajhashemi V, Vaseghi G, Pourfarzam M, Abdollahi A (2010) Are antioxidants helpful for disease prevention? Res Pharm Sci 5:1–8PubMedPubMedCentralGoogle Scholar
  22. He W, Li LX, Liao QJ, Liu CL, Chen XL (2011) Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication – inducible cell line. World J Gastroenterol 17:1507–1514CrossRefGoogle Scholar
  23. Hemilä H (2017) Vitamin C and infections. Nutrients 9:339CrossRefGoogle Scholar
  24. Isaguliants M, Smirnova O, Ivanov AV, Kilpelainen A, Kuzmenko Y, Petkov S, Latanova A, Krotova O, Engstrom G, Karpov V, Kochetkov S, Wahren B, Starodubova E (2013) Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme’s performance in gene immunization. Hum Vaccines Immunotherapeutics 9:2111–2119CrossRefGoogle Scholar
  25. Ivanov AV, Valuey-Ellistov VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B, Isaguliants MG (2016) Oxidative stress during HIV infection: mechanisms and consequences. Oxidative Med Cell Longev.  https://doi.org/10.1155/2016/8910396 CrossRefGoogle Scholar
  26. Kim MS, Kim DJ, Na CH, Shin BS (2016) A study of intravenous administration of vitamin C in the treatment of acute herpetic pain and postherpetic neuralgia. Ann Dermatol 28:677–683CrossRefGoogle Scholar
  27. Knight JA (2000) Review: free radicals, antioxidants and the immune system. Ann Clin Lab Sci 30:145–158PubMedGoogle Scholar
  28. Manago A, Becker KA, Carpinteiro A, Wilker B, Soddemann M, Seitz AP, Edwards MJ, Grassme H, Szabo I, Gulbins E (2015) Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase. Antioxid Redox Signal 22(13):1097–1110.  https://doi.org/10.1089/ars.2014.5979 CrossRefGoogle Scholar
  29. Medvedev R, Ploen D, Hildt E (2016) HCV and oxidative stress: implications for HCV life cycle and HCV- associated pathogenesis. Oxidative Med Cell Longev.  https://doi.org/10.1155/2016/9012580 CrossRefGoogle Scholar
  30. Mikirova NA, Hunninghake R (2014) Effect of high dose vitamin C on Epstein-Barr viral infection. Med Sci Monit Int Med J Exp Clin Res 20:725–732Google Scholar
  31. Mora JR, Iwata M, von Andrian UH (2008) Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8:685–698CrossRefGoogle Scholar
  32. Mori A, Nishino C, Enoki N, Tawata S (1987) Antibacterial antibacterial activity and mode of action of plant flavonoids against Proteus vulgaris and Staphylococcus aureus. Phytochemistry 26:2231–2234CrossRefGoogle Scholar
  33. Nakahara KS, Kawabata S, Ono H, Oqura K, Tanaka T, Ooshima T, Hamada S (1993) Inhibitory effect of oolong tea polyphenols on glucosyltransferases of mutans Streptococci. Appl Environ Microbiol 59:968–973PubMedPubMedCentralGoogle Scholar
  34. Ohemeng KA, Schwender CF, Fu KP, Barrett JF (1993) DNA gyrase inhibitory and antibacterial activity of some flavones. Bioorg Med Chem Lett 3:225–230CrossRefGoogle Scholar
  35. Ono K, Nakane H, Fukushima M, Chermann JC, Barré-Sinoussi F (1990) Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 190:469–476CrossRefGoogle Scholar
  36. Porter KM, Sutliff RL (2012) HIV-1, reactive oxygen species and vascular complications. Free Radic Biol Med 53:142–159CrossRefGoogle Scholar
  37. Radhakrishnan AK, Mahalingam D, Selvaduray KR, Nesaretnam K (2013) Supplementation with natural forms of vitamin E augments antigen-specific Th1-type immune response to tetanus toxoid. Biomed Res Int 2013:782067,8Google Scholar
  38. Regev-Yochay G, Trzcinski K, Thompson CM, Malley R, Lipsitch M (2006) Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol 188:4996–5001CrossRefGoogle Scholar
  39. Selway JWT (1986) Antiviral activity of flavones and flavans. In: Cody V, Middleton E, Harborne JB (eds) Plant flavonoids in biology and medicine: biochemical, pharmacological, and structure–activity relationships. Alan R. Liss, New York 1986Google Scholar
  40. Suárez B, Álvarez AL, García YD, Barrio YD, Lobo AP, Parra F (2010) Phenolic profiles, antioxidant activity and in vitro antiviral properties of apple pomace. Food Chem 120:339–342CrossRefGoogle Scholar
  41. Tsuchiya H, Iinuma M (2000) Reduction of membrane fluidity by antibacterial sophoraflavanone G isolated from Sophora exigua. Phytomedicine 7:161–165CrossRefGoogle Scholar
  42. Uozaki M, Ikeda K, Tsujimoto K, Nishide M, Yamasaki H, Khamsri B, Hajime Koyama A (2010) Antiviral effects of dehydroascorbic acid. Exp Ther Med 1:983–986CrossRefGoogle Scholar
  43. Wang GF, Shi LP, Ren YD, Liu QF, Liu HF, Zhang RJ, Li Z, Zhu FH, He PL, Tang W, Tao PZ, Li C, Zhao WM, Zuo JP (2009) Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. Antivir Res 83:186–190CrossRefGoogle Scholar
  44. Williamson MP, McCormick TG, Nance CL, Shearer WT (2006) Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J Allergy Clin Immunol 118:1369–1374CrossRefGoogle Scholar
  45. Young IS, Woodside JV (2001) Antioxidants in health and disease. J Clin Pathol 54:176–186CrossRefGoogle Scholar
  46. Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S (2011) Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol J 8:560CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Jasleen Kaur
    • 1
  • Rajvir Kaur
    • 1
  • Amarjeet Kaur
    • 1
  1. 1.Department of MicrobiologyGuru Nanak Dev UniversityAmritsarIndia

Personalised recommendations